Doctor profile · Federal record
Dr. Pallavi Nandeeshwar, M.D.
Rheumatology Physician (CMS: Rheumatology) · McKinney, TX
- NPI 1013013192
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 36 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1445 Heritage Dr
McKinney, TX 750693394
(972) 547-9700
fax (972) 547-1110
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- February 14, 2020
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Texas #K7357
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1013013192. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,711
Distinct HCPCS
10
Medicare allowed
$264,120
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 5,040 | 51 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 705 | 266 | $123 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 294 | 58 | $70 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 130 | 87 | $88 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 121 | 13 | $27 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 117 | 23 | $125 | |
J7050 |
Infusion, normal saline solution, 250 cc | 115 | 27 | $1 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 65 | 18 | $1 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 48 | 48 | $159 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 39 | 30 | $54 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 391. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$1,499
Transactions
66
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 24 | $374.28 | |
| ABBVIE INC. | 13 | $363.03 | |
| Mallinckrodt Hospital Products Inc. | 7 | $162.74 | |
| Janssen Scientific Affairs, LLC | 1 | $142.35 | |
| Lilly USA, LLC | 4 | $98.34 | |
| AstraZeneca Pharmaceuticals LP | 3 | $84.30 | |
| PFIZER INC. | 4 | $79.59 | |
| GlaxoSmithKline, LLC. | 3 | $54.24 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $44.25 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43.74 | |
| Novartis Pharmaceuticals Corporation | 2 | $31.10 | |
| SCILEX PHARMACEUTICALS INC. | 1 | $21.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,003
Patients
528
Total drug cost
$670,731
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 390 | 104 | $12,401 |
| Gabapentin | Generic | 306 | 69 | $4,815 |
| Hydroxychloroquine Sulfate | Generic | 269 | 81 | $19,692 |
| Prednisone | Generic | 212 | 43 | $2,071 |
| Tramadol Hcl | Generic | 107 | 20 | $687 |
| Folic Acid | Generic | 92 | 32 | $600 |
| Celecoxib | Generic | 87 | 30 | $2,152 |
| Meloxicam | Generic | 85 | 28 | $466 |
| Enbrel Sureclick (Etanercept) | Brand | 80 | 0 | $616,397 |
| Allopurinol | Generic | 78 | 22 | $1,233 |
Hospital affiliations
Frequently asked questions
What is Dr. Pallavi Nandeeshwar's medical specialty?
Dr. Pallavi Nandeeshwar practices Rheumatology Physician in McKinney, TX.
Where does Dr. Pallavi Nandeeshwar practice?
Dr. Pallavi Nandeeshwar practices at 1445 Heritage Dr, McKinney, TX 750693394. Office phone: 9725479700.
What is Dr. Pallavi Nandeeshwar's NPI?
Dr. Pallavi Nandeeshwar's National Provider Identifier (NPI) is 1013013192, issued by NPPES.
Does Dr. Pallavi Nandeeshwar accept Medicare assignment?
Yes. Dr. Pallavi Nandeeshwar accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Pallavi Nandeeshwar commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS 96401). Source: CMS Medicare Physician & Other Practitioners file.